DK233385D0 - Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet - Google Patents

Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet

Info

Publication number
DK233385D0
DK233385D0 DK233385A DK233385A DK233385D0 DK 233385 D0 DK233385 D0 DK 233385D0 DK 233385 A DK233385 A DK 233385A DK 233385 A DK233385 A DK 233385A DK 233385 D0 DK233385 D0 DK 233385D0
Authority
DK
Denmark
Prior art keywords
crl
human monoclonal
antibody
antibodies
separates
Prior art date
Application number
DK233385A
Other languages
English (en)
Other versions
DK233385A (da
Inventor
Anthony W Siadak
Mark E Lostrom
Original Assignee
Genitec Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24460190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK233385(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genitec Systems Corp filed Critical Genitec Systems Corp
Publication of DK233385D0 publication Critical patent/DK233385D0/da
Publication of DK233385A publication Critical patent/DK233385A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/803—Antibody or antigen-binding fragment thereof that binds gram-negative bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
    • Y10S424/807—Monoclonal
    • Y10S424/808—Human
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK233385A 1984-05-25 1985-05-24 Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet DK233385A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61418484A 1984-05-25 1984-05-25

Publications (2)

Publication Number Publication Date
DK233385D0 true DK233385D0 (da) 1985-05-24
DK233385A DK233385A (da) 1985-11-26

Family

ID=24460190

Family Applications (1)

Application Number Title Priority Date Filing Date
DK233385A DK233385A (da) 1984-05-25 1985-05-24 Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet

Country Status (16)

Country Link
US (1) US4834975A (da)
EP (1) EP0163493B1 (da)
JP (1) JPS6169796A (da)
KR (1) KR850008282A (da)
AT (1) ATE62021T1 (da)
AU (1) AU600222B2 (da)
DE (1) DE3582274D1 (da)
DK (1) DK233385A (da)
ES (1) ES8702792A1 (da)
FI (1) FI89278C (da)
GR (1) GR851234B (da)
HU (1) HU202927B (da)
IE (1) IE58411B1 (da)
IL (1) IL75277A (da)
NO (1) NO167758C (da)
ZA (1) ZA853888B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
JPS61152280A (ja) * 1984-12-26 1986-07-10 Teijin Ltd 抗緑膿菌ヒト抗体を産生する形質転換細胞及びその製造法並びにその使用方法
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
JPS61155398A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 抗緑膿菌ヒトモノクロ−ナル抗体及びその製造法並びにそれを有効成分とする治療剤
AU584690B2 (en) * 1985-03-11 1989-06-01 Teijin Limited E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
EP0494085A1 (en) 1985-09-27 1992-07-08 The Regents Of The University Of California Monoclonal antibodies binding determinants of gram negative bacteria
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
ZA87863B (en) * 1986-02-07 1987-09-30 Genetic Systems Corp Cross-protective human monoclonal antibody compositions
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
ES2009366A6 (es) * 1986-04-24 1989-09-16 Univ California Procedimiento de obtencion de anticuerpos monoclonales para bacterias gram-negativas.
GB8610202D0 (en) * 1986-04-25 1986-05-29 Technology Licence Co Ltd Monoclonal antibodies
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
ZA878610B (en) * 1986-11-20 1989-06-28 Minnesota Mining & Mfg Method for the evaluation of oral microbes
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
WO1988008135A1 (en) * 1987-04-10 1988-10-20 Xoma Corporation Human monoclonal antibodies binding determinants of gram negative bacteria
ES2045027T3 (es) * 1987-08-10 1994-01-16 Miles Inc Igm purificadas.
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
US5439665A (en) * 1988-07-29 1995-08-08 Immunomedics Detection and treatment of infectious and inflammatory lesions
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
US4939176A (en) * 1988-12-20 1990-07-03 Miles Inc. Viral inactivation process
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
US5233024A (en) * 1991-04-09 1993-08-03 The Brigham & Women's Hospital Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
US5824310A (en) * 1991-10-22 1998-10-20 The United States Of America As Represented By The Department Of Health And Human Services Lipopplysaccharide conjugate vaccines
ES2104855T3 (es) * 1991-12-24 1997-10-16 Wako Pure Chem Ind Ltd Procedimiento para extraer endotoxinas.
US5610031A (en) * 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
US5807694A (en) * 1995-09-07 1998-09-15 Economic Innovation And Technology Council, University Of Manitoba Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor
US6818222B1 (en) * 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
AU742076B2 (en) * 1997-05-15 2001-12-13 Veritas Therapeutics Inc. Methods of modulating immune coagulation
US6790661B1 (en) 1999-07-16 2004-09-14 Verax Biomedical, Inc. System for detecting bacteria in blood, blood products, and fluids of tissues
US20040106146A1 (en) * 2000-02-15 2004-06-03 Timo Palosuo Immunochemical methods
ATE458006T1 (de) * 2003-05-14 2010-03-15 Kenta Biotech Ag Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa
EP2417157A1 (en) 2009-04-09 2012-02-15 Kenta Biotech AG Human monoclonal antibody specific for lipolysaccarides (lps) of serotype lats 01 of pseudomonas aeruginosa
KR20120128686A (ko) * 2010-02-18 2012-11-27 심포젠 에이/에스 녹농균의 혈청형 ａ 지질다당류에 대한 항체
EP2361989A1 (en) * 2010-02-26 2011-08-31 Kenta Biotech AG Assays and kits for serotyping Pseudomonas aeruginosa and oligonucleotide sequences useful in such methods and kits

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU530649B2 (en) * 1981-01-28 1983-07-21 Coats Patons Plc Method of manufacturing monoclonal antibodies and capable of manufacturing such antibodies
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
AU567693B2 (en) * 1982-09-30 1987-12-03 University Of Rochester Human monoclonal antibodies against bacterial toxins
JPH0776240B2 (ja) * 1983-05-06 1995-08-16 ベロス グル−プ エンドトキシンコア−と反応性のモノクロ−ナル抗体
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria

Also Published As

Publication number Publication date
ES543474A0 (es) 1987-01-16
NO852093L (no) 1985-11-26
ZA853888B (en) 1986-01-29
IL75277A0 (en) 1985-09-29
EP0163493A3 (en) 1986-07-02
EP0163493B1 (en) 1991-03-27
AU4285885A (en) 1985-11-28
HUT38123A (en) 1986-04-28
DE3582274D1 (de) 1991-05-02
JPS6169796A (ja) 1986-04-10
FI89278C (fi) 1993-09-10
FI852029A0 (fi) 1985-05-21
GR851234B (da) 1985-07-01
HU202927B (en) 1991-04-29
ES8702792A1 (es) 1987-01-16
FI852029L (fi) 1985-11-26
EP0163493A2 (en) 1985-12-04
DK233385A (da) 1985-11-26
US4834975A (en) 1989-05-30
ATE62021T1 (de) 1991-04-15
FI89278B (fi) 1993-05-31
IL75277A (en) 1990-02-09
NO167758C (no) 1991-12-04
IE58411B1 (en) 1993-09-22
KR850008282A (ko) 1985-12-16
IE851302L (en) 1985-11-25
AU600222B2 (en) 1990-08-09
NO167758B (no) 1991-08-26

Similar Documents

Publication Publication Date Title
DK233385D0 (da) Humant monoclonalt antistof, praeparat indeholdende antistoffer og cellelinie, der udskiller antistoffet
SE8605295L (sv) Monoklonala antikroppar som er korsreaktiva och korsprotektiva mot p. aeruginosa-sero-typer
AU567693B2 (en) Human monoclonal antibodies against bacterial toxins
IL67721A (en) Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies
DE3176491D1 (en) Pasteurized therapeutically active protein compositions
MX9603773A (es) Anticuerpos monoclonales anti-interleucina-8 para el tratamiento de trastornos inflamatorios.
IL59919A (en) Monoclonal antibody of class igg to human helper t cells,its preparation and pharmaceutical and diagnostic compositions containing it
PL317536A1 (en) Monoclonal antibody against cd 44v6
AU5280186A (en) Canine parvovirus vaccines
HK21795A (en) Cross-protective human monoclonal antibody compositions
KR890700832A (ko) 그람 음성균의 항원 결정기와 결합하는 사람 단일클론성 항체
Mortensen et al. Ventilation tubes and cholesteatoma in children
OA08298A (fr) Nouvelles N-(aminométhyl-5 oxazolin-2 yl-2) N'-phénylurées, leur méthode de préparation ainsi que leur application thérapeutique.
AU6596390A (en) Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes
IT8721657A0 (it) Eteri e tioeteri ad attivita'terapeutica, loro preparazione e composizioni che li contengono.
IL80918A (en) Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes and pharmaceutical compositions and kits containing said antibodies
Borek Secretory immunity and infection: edited by JR McGhee, J. Mestecky and JL Babb. Plenum Press, New York, 1978 (905 pp., illus.) US $90.00
IT8322236A0 (it) Esteri dell'o-metossifenolo ad azione anti-infiammatori e espettorante, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8323603A0 (it) Esteri dell'o-metossifenolo ad azione anti-infiammatoria e espettorante, procedimento per laloro preparazione e composizione farmaceutiche che li contengono.
MX9605330A (es) Metodos y composiciones para el tratamiento de glomerulonefritis y otras enfermedades inflamatorias.
NO874799L (no) Fremgangsmaate for fremstilling av monoklonale antistofferved dyrking av hybridom-cellelinjen lym-2.
IT8421648A1 (it) Nuove difluoroepossidoeritromicine, il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i nuovi prodotti
IT8219456A0 (it) Composto ad attivita'analgesica e antiinfiammatoria ad azione protratta, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT7927837A0 (it) Procedimento migliorato per la fermentazione dell'etanolo.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment